Learn more

MEDEA RES SRL

Overview
  • Total Patents
    164
About

MEDEA RES SRL has a total of 164 patent applications. Its first patent ever was published in 1977. It filed its patents most often in Italy, EPO (European Patent Office) and Spain. Its main competitors in its focus markets organic fine chemistry, pharmaceuticals and machine tools are CELLCEUTIX CORP, NEOCULI PTY LTD and LATVIJAS ORGANISKAS SINTEZES I.

Patent filings per year

Chart showing MEDEA RES SRLs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Quadro Giuseppe 56
#2 Bruno Graziella 46
#3 Graziella Bruno 17
#4 Jiyuzetsupe Kuadoro 6
#5 Cahn Jean 4
#6 Galzigna Lauro 2
#7 Giuseppe Quadro 2
#8 Quadro G 2
#9 Ferruti Paolo 2
#10 Tanzi Maria Cristina 2

Latest patents

Publication Filing date Title
ITMI942542D0 Melatonin as a physiological agent for reequilibrating lymphocyte Th1/Th2 ratio
ITMI942543D0 Pharmaceutical compositions containing melatonin and oestrogen-receptor inhibitors
ITMI942165D0 (2-amino-3,5-dibromo)benzylamine derivative having antitussive and expectorant activity
ITMI942060D0 Use of midestein as a cicatrizing agent and corresponding topical pharmaceutical compositions
ITMI942061D0 Anthranilic acid derivative having immunostimulant activity
ITMI941865D0 Menthyl derivative, process for its preparation and pharmaceutical compositions containing it
ITMI941111D0 Melatonin as a chemoprotective agent
WO9219597A1 Gallic acid derivative, and pharmaceutical compositions containing it
WO9219612A1 Antiarteriosclerotic agent, a process for the preparation thereof and the use thereof
EP0557303A1 N- (2-thenoylmercapto-3-methyl)-butanoyl]-homocysteine thiolactone, a process for the preparation thereof and pharmaceutical compositions containing it
AU8332791A Oral pharmaceutical compositions containing melatonin
EP0504180A1 Glycyl-p-amino-pyridine for the treatment of senile dementia states
IT8822258D0 Compounds with spasmolytic action, their preparation and appropriate pharmaceutical compositions.
IT8820926D0 Anti-psoriasis agent based on papaverine salicylate
IT8820742D0 Therapeutically active potassium salt of di-peptide
IT8820658D0 Ferric salts contg. therapeutic compsn.
IT8819436D0 Carnitine derivs.
IT8622380D0 New spasmolytic compsn.
IT8621841D0 Chloro-promazine derivs.
IT8621733D0 Quinoline pyrido-pyrimidine or- pyridine derivs.